Objectives: Caffeine is a phytochemical naturally occurring in coffee and tea. Research suggests MCF-7 breast cancer cell viability decreases after exposure to millimolar (mM) amounts of caffeine in vitro. The effect of smaller amounts has not been fully investigated. In addition, caffeine and the risk for developing breast cancer has been investigated, but less research has addressed this relationship after a diagnosis. This study assessed the impact of micromolar (µM) concentrations of caffeine on MCF-7 cell proliferation, and gathered caffeine intake recommendations given to patients with breast cancer to evaluate whether these recommendations were based on current research.
Methods: MCF-7 cells were cultured for 24 hours with caffeine concentrations following a dilution curve from 10µM to 1.2mM, and 5mM. An XTT assay calculated cell proliferation. A REDCap online survey submitted to breast cancer support groups and social media sites gathered caffeine data from patients with breast cancer.
Results: XTT absorbance data combined from all three runs indicated differences in proliferation significance at 5mM caffeine concentration (p<0.001) compared to baseline (0µM of caffeine); however, the first run alone suggested significance at multiple caffeine concentrations including at 320µM (p=0.009), 640µM (p<0.001), and 1.2mM (p<0.001). Regarding survey results, of 40 survey participants, 38 received no caffeine recommendations from healthcare providers, 36 received no information from other sources regarding caffeine related to their diagnosis, and 30 indicated they drank caffeinated coffee, tea or soda daily.
Conclusions: This data reflects previous research indicating caffeine is cytotoxic to MCF-7 cells in vitro at 5mM, and further suggests micromolar concentrations of caffeine have a bimodal effect with potential initial proliferation increase, then increasing cytotoxic effect. The in vitro data suggests possible implications regarding caffeine intake and breast cancer cell cytotoxicity, while survey data indicates absence of caffeine recommendations after diagnosis.
|Advisor:||Kazaks, Alexandra, Conley, Melissa|
|Commitee:||Helsel, Diane, Messner, Don|
|Department:||Department of Nutrition|
|School Location:||United States -- Washington|
|Source:||MAI 81/3(E), Masters Abstracts International|
|Keywords:||Breast cancer, Caffeine, MCF-7|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be